Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis

Published 2018 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
Authors
Keywords
-
Journal
Drug Design Development and Therapy
Volume Volume 12, Issue -, Pages 3879-3883
Publisher
Dove Medical Press Ltd.
Online
2018-11-12
DOI
10.2147/dddt.s167149

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.